RCEL
AVITA Medical, Inc.
NASDAQ · USHealthcareMedical - Devices
$5.14+0.78%
Price as of Jul 20, 2026
RCEL financials
AVITA Medical, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $71.6M | $64.3M | $50.1M | $34.4M |
| Cost of revenue | $12.8M | $9.1M | $7.8M | $6.0M |
| Gross profit | $58.8M | $55.2M | $42.4M | $28.4M |
| Operating expenses | $101.3M | $111.8M | $85.0M | $55.9M |
| Operating income | -$42.5M | -$56.6M | -$42.7M | -$27.5M |
| Net income | -$48.6M | -$61.8M | -$35.4M | -$26.7M |
| EBITDA | -$41.2M | -$55.3M | -$33.5M | -$26.0M |
| Basic EPS | $-1.74 | $-2.39 | $-1.40 | $-1.07 |
| Diluted EPS | $-1.74 | $-2.39 | $-1.40 | $-1.07 |
| Balance sheet | ||||
| Cash & equivalents | $10.2M | $14.1M | $22.1M | $18.2M |
| Total assets | $56.4M | $79.7M | $111.6M | $98.3M |
| Total liabilities | $73.0M | $75.2M | $62.6M | $13.5M |
| Stockholders’ equity | -$16.6M | $4.5M | $49.1M | $84.7M |
| Total debt | $46.0M | $46.0M | $42.4M | $918.0K |
| Net debt | $35.8M | $31.9M | $20.3M | -$17.2M |
| Cash flow | ||||
| Operating cash flow | -$31.2M | -$48.9M | -$38.0M | -$19.1M |
| Capital expenditure | -$1.7M | -$9.3M | -$1.4M | -$525.0K |
| Free cash flow | -$32.9M | -$58.3M | -$39.5M | -$19.6M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |